Defense Secretary Pete Hegseth’s announcement that the Department of Defense will begin annual testosterone screenings for service members over the age of 30, coupled with voluntary testosterone replacement therapy, should concern every American—not because hormone replacement therapy is inherently wrong, but because of the ideology driving this decision.
Let’s be clear: when medically indicated, hormone replacement therapy is legitimate healthcare. Testosterone replacement has an appropriate place in medicine, just as estrogen, progesterone, insulin, thyroid hormone, and countless other treatments do.
What makes this announcement so troubling is the glaring double standard.
This same administration has spent years demonizing hormone replacement therapy when it is provided as medically necessary, evidence-based care for transgender people. Gender-affirming care has been portrayed as dangerous, immoral, and something government should aggressively prohibit. Yet now, hormone replacement therapy is suddenly being celebrated as a patriotic investment in masculinity and military strength.
Hormones apparently become acceptable when they reinforce one very narrow political definition of what a “real man” should be.
That isn’t medicine.
That’s ideology.
The language surrounding this initiative makes the motivation difficult to ignore. Branding the Pentagon as a “High-T Department of War” and framing testosterone as a marker of national strength reinforces a worldview that equates masculinity with aggression, dominance, and military virtue rather than leadership, wisdom, emotional resilience, or ethical judgment.
The military deserves evidence-based healthcare—not policies shaped by culture war slogans.
Even more troubling is what has gone unanswered. The Pentagon has not explained what clinical evidence supports population-wide screening under this program, nor has it clarified whether women in uniform—including those experiencing hormonal changes such as perimenopause—will receive comparable consideration for their healthcare needs.
That silence speaks volumes.
If hormone optimization is genuinely about troop readiness, then healthcare should be individualized, scientifically grounded, and available equitably to every service member.
If it is only about elevating testosterone while simultaneously restricting other forms of hormone therapy, then this is no longer a healthcare initiative. It is a political statement about whose bodies deserve medical autonomy and whose do not.
The irony is impossible to miss.
For years, transgender Americans have been told that hormone therapy is too controversial, too dangerous, too experimental, or too political to deserve public support—even though every major mainstream medical organization recognizes gender-affirming hormone therapy as appropriate treatment for many patients.
Now the federal government is enthusiastically promoting hormone replacement therapy under the banner of creating a more masculine military.
The issue has never been hormones.
The issue has always been whose hormones.
Healthcare should never be determined by political ideology. Medical decisions belong in consultation rooms between patients and qualified clinicians—not in campaign speeches, Pentagon branding exercises, or culture war messaging.
The Human Rights Alliance calls for evidence-based medicine, equal treatment under the law, and bodily autonomy for every person. We reject policies that elevate one form of medically supervised hormone therapy while criminalizing or stigmatizing another based solely on politics.
Justice demands consistency.
Science demands honesty.
And our service members deserve healthcare—not ideological theater.
M. A. D’Arrigo
HRA Board President